227 related articles for article (PubMed ID: 30106138)
1. Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.
Hu C; Zhou Y; Liu C; Kang Y
Oncol Rep; 2018 Nov; 40(5):2467-2476. PubMed ID: 30106138
[TBL] [Abstract][Full Text] [Related]
2. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
3. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
4. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
9. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
10. A risk assessment model for the prognosis of osteosarcoma utilizing differentially expressed lncRNAs.
Sun K; Zhao J
Mol Med Rep; 2019 Feb; 19(2):1128-1138. PubMed ID: 30569146
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
[TBL] [Abstract][Full Text] [Related]
12. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
[TBL] [Abstract][Full Text] [Related]
13. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
Xia P; Li Q; Wu G; Huang Y
Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Zhang D; Zhou H; Liu J; Mao J
Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
16. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
17. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis.
Li J; Yu X; Liu Q; Ou S; Li K; Kong Y; Liu H; Ouyang Y; Xu R
Mol Med Rep; 2019 May; 19(5):4067-4080. PubMed ID: 30896819
[TBL] [Abstract][Full Text] [Related]
18. Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer.
Xu N; Wu YP; Yin HB; Xue XY; Gou X
J Transl Med; 2018 Oct; 16(1):274. PubMed ID: 30286759
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of immune-related lncRNA in low-grade glioma.
Li X; Meng Y
BMC Cancer; 2019 Aug; 19(1):813. PubMed ID: 31419958
[TBL] [Abstract][Full Text] [Related]
20. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
